rs727503974
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_172107.4(KCNQ2):c.821C>T(p.Thr274Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_172107.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 7 Pathogenic:7Other:1
- -
This sequence variant is a single nucleotide substitution (C>T) at position 821 of the coding sequence of the KCNQ2 gene that results in a threonine to methionine amino acid change at residue 274 of the potassium voltage-gated channel subfamily Q member 2 protein. The 274 residue falls in a pore-forming domain (Uniprot) which plays a critical role in the regulation of neurol excitability mediated by KCNQ2. This is a de novo, previously reported variant (ClinVar 167208) that has been observed in the literature in many individuals affected by epileptic seizures (PMID: 2753503, 30776697, 31780880, 34711204). This variant is absent from the gnomAD population database (0 of ~250,000 alleles). Bioinformatic tools predict that this amino acid change would be damaging, and the Thr274 residue is highly conserved across the vertebrate species examined. Studies examining the functiol consequence of this variant confirms a significant reduction in conductance through this voltage-gated potassium channel protein (PMID: 24318194, PMID: 33336127). Based upon the evidence, we consider this variant to be pathogenic. ACMG Criteria: PM1, PM2, PP2, PP3, PS2, PS3, PS4 -
The variant has been previously reported as de novo in a similarly affected individual (PMID: 22275249, 27535030, PS2_S). It has been observed in multiple (>3) similarly affected unrelated individuals(PMID: 22275249, 27535030, 27779742, 28133863, PS4_S). Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 24318194, PS3_S). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.94, PP3_P). A missense variant is a common mechanism associated with Epileptic encephalopathy (PP2_P). It is not observed in the gnomAD v2.1.1 dataset (PM2_M). The variant is located in a well-established functional domain or exonic hotspot, where pathogenic variants have frequently reported (PM1_M).Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
EE (epileptic encephalopathy) -
- -
- -
- -
- -
not provided Pathogenic:5
Published functional studies demonstrate a damaging effect, as current amplitudes of homotetramers and heterotetramers were reduced (Orhan et al., 2014); Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; The majority of missense variants in this gene are considered pathogenic (HGMD); This variant is associated with the following publications: (PMID: 22275249, 29056246, 28133863, 27779742, 31273778, 20437616, 27602407, 23692823, 25960349, 28488083, 30776697, 27535030, 31780880, 33041849, 32239694, 33822359, 34055682, 33098118, 31175295, 31440721, 35217970, 24318194) -
- -
- -
- -
- -
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 274 of the KCNQ2 protein (p.Thr274Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with early infantile epileptic encephalopathy (PMID: 22275249, 27535030, 27779742, 28133863). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 167208). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt KCNQ2 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KCNQ2 function (PMID: 24318194). For these reasons, this variant has been classified as Pathogenic. -
Seizures, benign familial neonatal, 1 Pathogenic:1
- -
West syndrome Pathogenic:1
- -
Complex neurodevelopmental disorder Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at